Navigation Links
PATHFAST(R): Rapid Whole Blood Immunoassay Analyzer from Polymedco
Date:4/11/2008

CORTLANDT MANOR, N.Y., April 11 /PRNewswire/ -- Polymedco, Inc. is pleased to announce the introduction of the PATHFAST immunoassay analyzer. The PATHFAST rapid point of care system utilizes a chemiluminescent technology combined with a unique magtration separation method that allows this system to report highly accurate results that compare to large platform instruments. The PATHFAST system employs individual cartridge-based technology utilizing a whole blood sample.

The PATHFAST system can handle six samples in batch or random access mode and report these six results in 17 minutes. The PATHFAST analyzer and NTproBNP assay have recently been 510(k) cleared by the FDA. Polymedco has submitted another assay with the FDA and will file three more by the end of April. Polymedco expects to have seven assays cleared by the end of 2008. The initial menu will be related to cardiac proteins, fibrin degradation products, high sensitive c-reactive protein and beta human chorionic gonadotropin.

The PATHFAST system is a small, compact platform, which includes a computer, LCD touch screen and printer and measures W14.7" x D22.4" x H20.0". This self contained unit can easily fit on any laboratory bench. Its user friendly operation allows the technician to simply add blood to the cartridges, place them on the system and press the start button. The technician returns in 17 minutes to read the results. This sensitive technology will allow the laboratory to report NTproBNP results from 15-30,000 pg/mL.

Polymedco, Inc. is a leading manufacturing, marketing and sales company that specializes in bringing innovative equipment and diagnostic kits to the medical market.

For more information, please contact Polymedco at 800-431-2123 or 914-739-5400 or visit our website: http://www.polymedco.com


'/>"/>
SOURCE Polymedco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Sewer-gas-induced suspended animation is rapid and reversible
2. STMicroelectronics and Veredus Laboratories Launch Markets First Lab-on-Chip for Rapid Molecular Flu Detection at Point of Need
3. Cardiums InnerCool Therapies Unit Announces Australian Distribution Agreement for CoolBlue and Rapid Blue Systems
4. Varian Announces Global Clinical Council to Develop RapidArc(TM) Cancer Treatments
5. HHS Deputy Secretary Recognizes Grand Rapids Leaders for Improving Quality and Value in Health Care
6. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
7. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
8. Mybank Goes Live With Misys Equation to Support Rapid Growth and Meet Future Regulatory Requirements
9. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
10. Forsyth launches 1-of-a-kind core service to enable rapid identification of bacterial samples
11. Varian Medical Systems Receives FDA 510(k) Clearance for RapidArc(TM) Radiotherapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... The report “Micronutrient Market by Type (Zinc, Manganese, ... Chelated), Application Mode (Soil, Foliar, Fertigation), Crop Type ... 2018” defines and segments the global agriculture micronutrients ... global value and volume for agriculture micronutrients. It ... the global agriculture micronutrients market with an analysis ...
(Date:7/13/2014)... 2014 According to a new ... Market by Component (processor, GPU, DSP, connectivity), Technology ... and Geography - Forecast and Analysis to 2014-2020", ... & Computing Market is expected to reach $61.70 ... 20.75% from 2014 to 2020. , Browse 71 ...
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, 2014 ... people with diabetes is being developed to measure sugar levels ... Scientists at Brown University in Providence, R.I., created the ... light, metal and a special enzyme that changes color when ... to prick their fingers to draw blood to check their ...
(Date:7/13/2014)... New York (PRWEB) July 13, 2014 ... ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against Johnson & ... second bellwether trial, which is expected to get underway ... issued in the U.S. District Court, Southern District of ... will be held on August 7, 2014 at 3:00 ...
(Date:7/13/2014)... MyDressCity.com, one of the most popular suppliers of wedding ... new range of elegant Quinceanera dresses . What’s ... prices. Worldwide clients can enjoy this special offer before ... shop, there are plenty of beautiful dresses for sale, ... MyDressCity.com’s hot items are prom gowns, bridesmaid gowns, wedding ...
Breaking Medicine News(10 mins):Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 2Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 3Health News:Micronutrient Market Worth $6,474.6 Million by 2018 - A Report by MarketsandMarkets 4Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 2Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 3Health News:Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports 4Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2
... repair damage with natural tissue , THURSDAY, Feb. 4 ... cartilage growth in joints has been developed by U.S. ... joint and stimulates bone marrow stem cells to produce ... No current therapy can do this, according to the ...
... typical 30-hour shifts need to be cut to 16 to ... In November 2000, Helen Haskell took her 15-year-old son to ... Four days later, he was dead. The cause: failure to ... to recognize and act upon declines in patients." , He ...
... , GAINESVILLE, Fla. , Feb. 4 ... announce today that they have jointly selected Sg2 , a healthcare ... children,s hospital. The assessment began in January with findings projected to be ... at Sg2 will handle this very important assessment, delivering the ...
... , , TORRANCE, ... the largest privately held insurance brokerage and consulting firm in ... providers of integrated disease management and wellness programs.  Nurtur and ... program providers, adding an important dimension to the company,s extensive ...
... , , NEW YORK , ... Parkinson,s Research today announced more than $2.8 million ... of biomarkers of PD. The development of biomarkers is of ... therapeutic development, allowing scientists and clinicians to more accurately identify ...
... , Feb 4 Smart Balance, Inc. (Nasdaq: SMBL ... February 25, 2010 , at 9:30 a.m. ET to ... 8:30 a.m. ET the same day.  The webcast will be in ... by dialing 1-800-895-0198 from the United States or 1-785-424-1053 from ...
Cached Medicine News:Health News:Nanofiber Gel May Spur Growth of New Knee Cartilage 2Health News:Campaign Calls for Limits on Doctors' Hours 2Health News:Campaign Calls for Limits on Doctors' Hours 3Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 2Health News:Sebastian Ferrero Foundation and Shands HealthCare Have Selected Sg2 to Conduct a Needs Assessment for a Gainesville-Based Children's Hospital 3Health News:Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs 2Health News:Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs 3Health News:Keenan Selects Nurtur and Healthyroads for Integrated Disease Management and Personal Wellness Programs 4Health News:Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline 2Health News:Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline 3Health News:Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinson's Disease Biomarker Pipeline 4Health News:Smart Balance to Host Webcast/Conference Call on 2009 Fourth-Quarter Results 2
(Date:7/10/2014)... Utah , July 10, 2014  BC Technical, ... and MiE America , Inc., a leading provider ... entered into a long-term agreement naming BC Technical as ... US. MiE and BC Technical announced ... agreement to establish BC Technical as the service and ...
(Date:7/10/2014)... Mass. , July 10, 2014  Decision ... of surveyed infectious disease (ID) specialists are willing ... Company,s Orbactiv (oritavancin) for use as OPAT, approximately ... prescribe these agents to their hospital inpatients. However, ... of OPAT patients are initiated on OPAT following ...
(Date:7/10/2014)... , July 10, 2014 Decision Resources Group ... of the U.S. Food and Drug Administration,s (FDA) approval ... binder Velphoro, which was approved by the FDA in ... kidney disease (CKD) patients on dialysis. Other ... Nephrology (US) Q2 2014 : ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... Inc. (Nasdaq: ANTH ), today announced financial results ... Financial Results: Total operating ... $18.7 million, as compared to $6.5 million for the same ... quarter of 2011 were driven by expenses related to site ...
... STAAR Surgical Company (NASDAQ: STAA ), ... ophthalmic products, today reported financial results for the first ... increased 8% to $14.8 million over the first quarter ... (IOL and ICL) sales.  The Company achieved its first ...
Cached Medicine Technology:Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 2STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 3STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 4STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 5STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 6STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 7STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 8STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 9STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 10STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000 11
... The MEL 80 is a top quality ... the correction of vision defects even safer, ... of this ultramodern work platform are oriented ... and the rapid recovery of vision. Key ...
Code-Ready defibrillator a defibrillator designed to provide clinicians with comprehensive support for resuscitation....
... be mounted at the patient's bedside, on ... The design retains many of the proven ... the pump drive motor circuits, flow estimator, ... system. Retaining these subsystems maintains compatibility ...
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
Medicine Products: